Data as of May 17
| -0.13 / -0.21%|
The 9 analysts offering 12-month price forecasts for Aegerion Pharmaceuticals Inc have a median target of 58.00, with a high estimate of 85.00 and a low estimate of 48.00. The median estimate represents a -5.80% decrease from the last price of 61.57.
The current consensus among 10 polled investment analysts is to Buy stock in Aegerion Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.